People
Since reports surfaced that Martin Shkreli used a contraband cellular phone to conduct business from behind bars, the controversial biotech bad boy investor has not been heard from. And it may be because he is currently in solitary confinement.
Jeff Mayhew, LabConnect’s Chief Development Officer, took time to speak with BioSpace about the company and the Seattle area. Mayhew is also one of the founders of LabConnect, which was started in 2002 and relocated to Seattle in 2004.
It is with deep regret that the Agency for Science, Technology and Research announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning.
Chris Mansur and Ryan Ott, both Azzur Group veterans, assume new appointments following the Group’s growth and further diversification.
In five years it is estimated that about 25,000 people in the United States will develop bronchiolitis obliterans syndrome (BOS), which results in respiratory failure and death. But a late-stage treatment under development by Breath Therapeutics could be a possible remedy for this rare and dread disease.
A review of top officials at Memorial Sloan Kettering Cancer Center found that there were repeated violations on financial conflicts of interest. The review was conducted by law firm Debevoise & Plimpton and jointly reported by The New York Times and ProPublica.
Sino-American relations continue to show signs of strain after the administration of President Donald Trump ordered the Chinese majority owner of healthcare company PatientsLikeMe to sell his stake.
Pharma, biotech and life science companies strengthen leadership teams, with news from Vertex, Arvinas, Provention, Enterome, and more.
The lawsuit alleges that Soon-Shiong acquired the promising cancer treatment in order to prevent it from coming to market and challenging revenues from Celgene’s Abraxane, a drug Soon-Shiong developed.
BioSTL is a regional organization in St. Louis whose goal is to champion the life sciences in St. Louis and the surrounding region. BioGenerator is the investment arm of BioSTL.
PRESS RELEASES